arrow_back Back to App

Prioritizing COVID-19 Vaccines for Taiwan and Latin American Allies

This act aims to ensure that Taiwan and key Latin American allies receive prioritized access to U.S. COVID-19 vaccines. This means a portion of doses will be reserved for them before vaccines are distributed to other countries. These actions are intended to strengthen relationships with these regions.
Key points
At least 25% of U.S. vaccines intended for international distribution will be reserved for Taiwan and crucial Latin American allies.
Vaccine distribution to other countries will only be possible after Taiwan and allies receive their first shipment.
Vaccine distribution will not be allowed to countries engaged in systemic human rights abuses.
The act will terminate once Taiwan and crucial Latin American allies achieve 40% vaccination rates for their populations.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_4362
Sponsor: Rep. Gimenez, Carlos A. [R-FL-26]
Process start date: 2021-07-06
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Curbing China’s Vaccine Diplomacy Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_4362.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-07-06.

What are the main provisions?

Key points include:

  • At least 25% of U.S. vaccines intended for international distribution will be reserved for Taiwan and crucial Latin American allies.
  • Vaccine distribution to other countries will only be possible after Taiwan and allies receive their first shipment.
  • Vaccine distribution will not be allowed to countries engaged in systemic human rights abuses.
  • The act will terminate once Taiwan and crucial Latin American allies achieve 40% vaccination rates for their populations.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Gimenez, Carlos A. [R-FL-26].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Asia, the Pacific, Central Asia and Nonproliferation.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health Security